Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | Day Return | YTD Return |
|---|---|---|---|
| All Industries | 100% | 0.05% | 1.88% |
| Drug Manufacturers - General | 34.18% | 1.46% | 7.85% |
| Healthcare Plans | 13.27% | -0.66% | -5.75% |
| Medical Devices | 12.92% | -0.61% | 3.61% |
| Diagnostics & Research | 11.44% | -0.97% | 2.01% |
| Biotechnology | 11.09% | -0.41% | -7.95% |
| Medical Instruments & Supplies | 6.67% | -0.39% | 2.60% |
| Medical Care Facilities | 2.91% | 0.21% | 9.21% |
| Drug Manufacturers - Specialty & Generic | 2.74% | -0.30% | -6.64% |
| Medical Distribution | 2.44% | -0.28% | 10.68% |
| Health Information Services | 2.10% | -3.35% | 5.17% |
| Pharmaceutical Retailers | 0.24% | -1.37% | -31.71% |
Note: Percentage % data on heatmap indicates Day Return
All Industries
-
Largest Companies in This Sector
|
Name
|
Last Price
|
1Y Target Est.
|
Market Weight
|
Market Cap
|
Day Change %
|
YTD Return
|
Avg. Analyst Rating
|
|---|---|---|---|---|---|---|---|
| 774.70 | 826.94 | 11.62% |
|
|
|
Buy
|
|
| 483.43 | 566.61 | 7.02% |
|
|
|
Buy
|
|
| 145.42 | 162.32 | 5.53% |
|
|
|
Buy
|
|
| 130.11 | 140.82 | 5.20% |
|
|
|
Buy
|
|
| 162.50 | 184.07 | 4.54% |
|
|
|
Buy
|
|
| 572.92 | 616.78 | 3.45% |
|
|
|
Buy
|
|
| 106.18 | 118.35 | 2.91% |
|
|
|
Buy
|
|
| 245.47 | 252.85 | 2.87% |
|
|
|
Buy
|
|
| 273.73 | 286.05 | 2.32% |
|
|
|
Buy
|
|
| 25.70 | 29.05 | 2.30% |
|
|
|
Buy
|
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
|
Name
|
Last Price
|
Net Assets
|
Expense Ratio
|
YTD Return
|
|---|---|---|---|---|
| 140.50 | 41.319B | 0.09% |
|
|
| 256.67 | 21.195B | 0.10% |
|
|
| 127.33 | 7.632B | 0.45% |
|
|
| 85.01 | 7.551B | 0.35% |
|
|
| 55.20 | 5.76B | 0.40% |
|
Mutual Fund Opportunities
|
Name
|
Last Price
|
Net Assets
|
Expense Ratio
|
YTD Return
|
|---|---|---|---|---|
| 207.26 | 47.432B | 0.29% |
|
|
| 87.39 | 47.432B | 0.29% |
|
|
| 128.38 | 21.195B | 0.10% |
|
|
| 90.22 | 15.399B | 0.80% |
|
|
| 92.74 | 15.399B | 0.80% |
|
Healthcare Research
Discover the Latest Analyst and Technical Research for This Sector
-
Analyst Report: Novartis AG
Novartis is a pharmaceutical company based in Switzerland. Its portfolio is focused primarily on the areas of Immunology, Neuroscience, Oncology, Cardiovascular, Renal, and Metabolic therapies. The company employs more than 78,000 people and its medicines reach more than 280 million people worldwide.
RatingPrice Target -
Daily – Vickers Top Insider Picks for 04/30/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
-
Market Digest: NVS, AN, AVB, BA, DPZ, GOOGL, KMB, SNAP
With earnings season in full swing, the volume of insider transactions has fallen to seasonal lows, with only 615 transactions meeting the criteria for inclusion in Vickers Weekly Insider Report. While that is down from the recent weekly high of 2,284 transactions, there is still noteworthy data to consider.
-
Analyst Report: West Pharmaceutical Services, Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
RatingPrice Target
